drugset

drugset / Trial / NCT00331916

AL-15469A for the Treatment of Bacterial Conjunctivitis

NCT00331916 ↗

Phase 3 Completed 600 enrolled Alcon Research

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.

Timeline

Start: 2005-11
Primary completion: 2007-05
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Moxifloxacin	Small molecule	—	—

Indications